The global target sequencing and resequencing market size accounted for USD 8.69 billion in 2024, grew to USD 10.70 billion in 2025 and is expected to be worth around USD 69.23 billion by 2034, registering a CAGR of 23.06% between 2024 and 2034. The North America target sequencing and resequencing market size is calculated at USD 4.35 billion in 2024 and is estimated to grow at a CAGR of 23.19% during the forecast period.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Target Sequencing and Resequencing Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Target Sequencing and Resequencing Market, by Technology, 2024-2034
8.1.1. Sequencing
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Re-sequencing
8.1.2.1. Market Revenue and Forecast (2021-2034)
9.1. Target Sequencing and Resequencing Market, by Application, 2024-2034
9.1.1. Clinical application
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Plant and animal sciences
9.1.2.1. Market Revenue and Forecast (2021-2034)
9.1.3. Drug development
9.1.3.1. Market Revenue and Forecast (2021-2034)
9.1.4. Others
9.1.4.1. Market Revenue and Forecast (2021-2034)
10.1. Target Sequencing and Resequencing Market, by March, 2024-2034
10.1.1. DNA-based targeted sequencing
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. RNA-based targeted sequencing
10.1.2.1. Market Revenue and Forecast (2021-2034)
11.1. Target Sequencing and Resequencing Market, by End-Use, 2024-2034
11.1.1. Hospitals & clinics
11.1.1.1. Market Revenue and Forecast (2021-2034)
11.1.2. Academic research
11.1.2.1. Market Revenue and Forecast (2021-2034)
11.1.3. Others
11.1.3.1. Market Revenue and Forecast (2021-2034)
12.1. North America
12.1.1. Market Revenue and Forecast, by Technology (2021-2034)
12.1.2. Market Revenue and Forecast, by Application (2021-2034)
12.1.3. Market Revenue and Forecast, by Type(2021-2034)
12.1.4. Market Revenue and Forecast, by End-Use (2021-2034)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Technology (2021-2034)
12.1.5.2. Market Revenue and Forecast, by Application (2021-2034)
12.1.5.3. Market Revenue and Forecast, by Type(2021-2034)
12.1.5.4. Market Revenue and Forecast, by End-Use (2021-2034)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Technology (2021-2034)
12.1.6.2. Market Revenue and Forecast, by Application (2021-2034)
12.1.6.3. Market Revenue and Forecast, by Type(2021-2034)
12.1.6.4. Market Revenue and Forecast, by End-Use (2021-2034)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Technology (2021-2034)
12.2.2. Market Revenue and Forecast, by Application (2021-2034)
12.2.3. Market Revenue and Forecast, by Type(2021-2034)
12.2.4. Market Revenue and Forecast, by End-Use (2021-2034)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Technology (2021-2034)
12.2.5.2. Market Revenue and Forecast, by Application (2021-2034)
12.2.5.3. Market Revenue and Forecast, by Type(2021-2034)
12.2.5.4. Market Revenue and Forecast, by End-Use (2021-2034)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Technology (2021-2034)
12.2.6.2. Market Revenue and Forecast, by Application (2021-2034)
12.2.6.3. Market Revenue and Forecast, by Type(2021-2034)
12.2.6.4. Market Revenue and Forecast, by End-Use (2021-2034)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Technology (2021-2034)
12.2.7.2. Market Revenue and Forecast, by Application (2021-2034)
12.2.7.3. Market Revenue and Forecast, by Type(2021-2034)
12.2.7.4. Market Revenue and Forecast, by End-Use (2021-2034)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Technology (2021-2034)
12.2.8.2. Market Revenue and Forecast, by Application (2021-2034)
12.2.8.3. Market Revenue and Forecast, by Type(2021-2034)
12.2.8.4. Market Revenue and Forecast, by End-Use (2021-2034)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Technology (2021-2034)
12.3.2. Market Revenue and Forecast, by Application (2021-2034)
12.3.3. Market Revenue and Forecast, by Type(2021-2034)
12.3.4. Market Revenue and Forecast, by End-Use (2021-2034)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Technology (2021-2034)
12.3.5.2. Market Revenue and Forecast, by Application (2021-2034)
12.3.5.3. Market Revenue and Forecast, by Type(2021-2034)
12.3.5.4. Market Revenue and Forecast, by End-Use (2021-2034)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Technology (2021-2034)
12.3.6.2. Market Revenue and Forecast, by Application (2021-2034)
12.3.6.3. Market Revenue and Forecast, by Type(2021-2034)
12.3.6.4. Market Revenue and Forecast, by End-Use (2021-2034)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Technology (2021-2034)
12.3.7.2. Market Revenue and Forecast, by Application (2021-2034)
12.3.7.3. Market Revenue and Forecast, by Type(2021-2034)
12.3.7.4. Market Revenue and Forecast, by End-Use (2021-2034)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Technology (2021-2034)
12.3.8.2. Market Revenue and Forecast, by Application (2021-2034)
12.3.8.3. Market Revenue and Forecast, by Type(2021-2034)
12.3.8.4. Market Revenue and Forecast, by End-Use (2021-2034)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Technology (2021-2034)
12.4.2. Market Revenue and Forecast, by Application (2021-2034)
12.4.3. Market Revenue and Forecast, by Type(2021-2034)
12.4.4. Market Revenue and Forecast, by End-Use (2021-2034)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Technology (2021-2034)
12.4.5.2. Market Revenue and Forecast, by Application (2021-2034)
12.4.5.3. Market Revenue and Forecast, by Type(2021-2034)
12.4.5.4. Market Revenue and Forecast, by End-Use (2021-2034)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Technology (2021-2034)
12.4.6.2. Market Revenue and Forecast, by Application (2021-2034)
12.4.6.3. Market Revenue and Forecast, by Type(2021-2034)
12.4.6.4. Market Revenue and Forecast, by End-Use (2021-2034)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Technology (2021-2034)
12.4.7.2. Market Revenue and Forecast, by Application (2021-2034)
12.4.7.3. Market Revenue and Forecast, by Type(2021-2034)
12.4.7.4. Market Revenue and Forecast, by End-Use (2021-2034)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Technology (2021-2034)
12.4.8.2. Market Revenue and Forecast, by Application (2021-2034)
12.4.8.3. Market Revenue and Forecast, by Type(2021-2034)
12.4.8.4. Market Revenue and Forecast, by End-Use (2021-2034)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Technology (2021-2034)
12.5.2. Market Revenue and Forecast, by Application (2021-2034)
12.5.3. Market Revenue and Forecast, by Type(2021-2034)
12.5.4. Market Revenue and Forecast, by End-Use (2021-2034)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Technology (2021-2034)
12.5.5.2. Market Revenue and Forecast, by Application (2021-2034)
12.5.5.3. Market Revenue and Forecast, by Type(2021-2034)
12.5.5.4. Market Revenue and Forecast, by End-Use (2021-2034)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Technology (2021-2034)
12.5.6.2. Market Revenue and Forecast, by Application (2021-2034)
12.5.6.3. Market Revenue and Forecast, by Type(2021-2034)
12.5.6.4. Market Revenue and Forecast, by End-Use (2021-2034)
13.1. Illumina, Inc.
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Agilent Technologies
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Thermo Fisher Scientific, Inc.
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. F. Hoffmann-La Roche Ltd
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. DNASTAR Inc.
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Bio-Rad Laboratories, Inc.
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. PacBio
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Integrated DNA Technologies, Inc.
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. RainDance Technologies, Inc.
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Perkin Elmer, Inc.
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample